Insights

Innovative Autism Therapy JelikaLite is developing the Cognilum system, a non-invasive, wearable device utilizing near-infrared light therapy combined with AI for treating autism symptoms, presenting a unique integrated solution that can appeal to clinics, healthcare providers, and educational institutions seeking novel therapeutic options.

Growing Market Focus With a rising incidence of autism and a societal need to reduce lifelong care costs, JelikaLite’s focus on pediatric neurological health offers considerable market potential, especially for payors and government agencies aiming to enhance quality of life while controlling expenditure.

Partnership Opportunities Collaborations with medical device companies like Brain Scientific indicate a strategic path for JelikaLite to expand clinical validation and distribution channels, highlighting avenues for sales partnerships and joint ventures in neurotherapeutic markets.

Cost-Effective Solutions By offering home-based, personalized, and potentially cost-effective therapies, JelikaLite’s solutions address a key buyer interest in scalable, non-invasive treatments that can reduce the need for costly special education and residential care services.

Early Growth Indicators With revenue estimates between $1 million and $10 million and recent developments in therapeutic device research, JelikaLite presents a promising client-facing opportunity for medical device distributors and healthcare systems seeking innovative autism intervention tools.

JelikaLite Tech Stack

JelikaLite uses 8 technology products and services including RSS, JSON-LD, Priority Hints, and more. Explore JelikaLite's tech stack below.

  • RSS
    Content Management System
  • JSON-LD
    Javascript Frameworks
  • Priority Hints
    Performance
  • Yoast SEO
    Search Engines
  • Cloudflare Bot Management
    Security
  • Vimeo
    Video Players
  • Contact Form 7
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

JelikaLite's Email Address Formats

JelikaLite uses at least 1 format(s):
JelikaLite Email FormatsExamplePercentage
First.Last@jelikalite.comJohn.Doe@jelikalite.com
25%
First@jelikalite.comJohn@jelikalite.com
25%
First.Last@jelikalite.comJohn.Doe@jelikalite.com
25%
First@jelikalite.comJohn@jelikalite.com
25%

Frequently Asked Questions

Where is JelikaLite's headquarters located?

Minus sign iconPlus sign icon
JelikaLite's main headquarters is located at 30 Wall Street 8th Floor New York, New York United States. The company has employees across 1 continents, including North America.

What is JelikaLite's official website and social media links?

Minus sign iconPlus sign icon
JelikaLite's official website is jelikalite.com and has social profiles on LinkedInCrunchbase.

What is JelikaLite's NAICS code?

Minus sign iconPlus sign icon
JelikaLite's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does JelikaLite have currently?

Minus sign iconPlus sign icon
As of April 2026, JelikaLite has approximately 6 employees across 1 continents, including North America. Key team members include Chief Operating Officer: L. L.Co-Founder And Ceo: K. S.Co-Founder: E. S.. Explore JelikaLite's employee directory with LeadIQ.

What industry does JelikaLite belong to?

Minus sign iconPlus sign icon
JelikaLite operates in the Medical Equipment Manufacturing industry.

What technology does JelikaLite use?

Minus sign iconPlus sign icon
JelikaLite's tech stack includes RSSJSON-LDPriority HintsYoast SEOCloudflare Bot ManagementVimeoContact Form 7Apache HTTP Server.

What is JelikaLite's email format?

Minus sign iconPlus sign icon
JelikaLite's email format typically follows the pattern of First.Last@jelikalite.com. Find more JelikaLite email formats with LeadIQ.

When was JelikaLite founded?

Minus sign iconPlus sign icon
JelikaLite was founded in 2019.

JelikaLite

Medical Equipment ManufacturingNew York, United States2-10 Employees

Autism is a serious developmental disease that lasts a lifetime. The rates of autism continue to rise, the cause of the disease remains unknown and there is no cure. We believe that children on the autism spectrum can lead fulfilling and productive lives. That is why JelikaLite is developing Cognilum, an integrative solution with focus on pediatric neurological health using non-invasive novel therapies. 
Cognilum will enable children to integrate into society, parents to receive a home-based personalized cost-effective treatment while having a better quality of life, therapists to track progress and efficacy of existing interventions, and both payors and government to spend less money on special education and lifelong residential care. 
Cognilum may provide benefits that may be difficult to measure with money alone, yet society will bear the ultimate expenses if nothing continues to be done about the millions of children with autism and other neurological disorders who are unable to integrate into society.

Section iconCompany Overview

Headquarters
30 Wall Street 8th Floor New York, New York United States
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    JelikaLite's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    JelikaLite's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.